title: Rational use of moxifloxacin for tuberculosis treatment.
authors: Burnet Institute, Melbourne, Victoria 3001, Australia. hcox@burnet.edu.au
authors: Helen
authors: H
authors: Cox
authors: Nathan
authors: N
authors: Ford
authors: Salmaan
authors: S
authors: Keshavjee
authors: Cheryl
authors: C
authors: McDermid
authors: Tido
authors: T
authors: von Schoen-Angerer
authors: Carole
authors: C
authors: Mitnick
authors: Eric
authors: E
authors: Goemaere
mesh_terms: D000995:Antitubercular Agents / Q000627:therapeutic use*; D001372:Aza Compounds / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D024841:Fluoroquinolones; D006801:Humans; D000077266:Moxifloxacin; D009169:Mycobacterium tuberculosis / Q000187:drug effects*; D011804:Quinolines / Q000627:therapeutic use*; D016896:Treatment Outcome; D014376:Tuberculosis / Q000188:drug therapy*
chemical_list: D000995:Antitubercular Agents; D001372:Aza Compounds; D024841:Fluoroquinolones; D011804:Quinolines; D000077266:Moxifloxacin